Liz Ann Sonders, the Chief Investment Strategist at Charles Schwab & Co. (NYSE: SCHW) highlighte

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

The mean of analysts' price targets for Vigil Neuroscience (VIGL) points to a 26.1% upside in the st

NEW YORK , June 9, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigat

The average of price targets set by Wall Street analysts indicates a potential upside of 26.9% in Vi

PHILADELPHIA , June 4, 2025 /PRNewswire/ -- The law firm of Kaskela Law LLC announces that it is inv

WATERTOWN, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clini

After reaching an important support level, Vigil Neuroscience, Inc. (VIGL) could be a good stock pic

NYC, May 24, 2025 (GLOBE NEWSWIRE) -- NEW YORK, May 24, 2025 / GlobeNewswire/ -- Class Action Attorn

The consensus price target hints at an 86.7% upside potential for Vigil Neuroscience (VIGL). While e

U.S. stock futures were fluctuating on Friday after a mixed close on Thursday. Futures of benchmark

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Vigil (Nasdaq: VIGL) for possible breach

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

Sanofi has entered an agreement to acquire Vigil Neuroscience for approximately $470 million, adding

- Vigil's shareholders to receive up to $10.00 per share in cash, comprised of $8.00 per share in ca

Sanofi said on Thursday that it would acquire Vigil Neuroscience, a clinical-stage biotech company,

– On track to report final analysis from IGNITE Phase 2 clinical trial evaluating iluzanebart in ALS

- Preclinical presentation highlights key, modality specific, pharmacological differentiations of VG

Vigil Neuroscience (VIGL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism ab

– Announced positive data from Phase 1 clinical trial evaluating VG-3927 for potential treatment of

WATERTOWN, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clin

Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance.

Gainers

  On Thursday, 283 companies set new 52-week lows.

  On Wednesday, 155 companies set new 52-week lows.

  During Tuesday's trading, 188 companies set new 52-week lows.

Gainers

U.S. stocks traded mixed, with the Dow Jones gaining over 50 points on Friday. Here are some big sto

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announce

U.S. stocks closed lower on Monday, with the Nasdaq dropping more than 100 points. Here is the list

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monda

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announce

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday afte

Gainers

Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares jumped 170.1% to close at $0.1194 on Tue

Gainers Nutex Health Inc. (NASDAQ: NUTX) jumped 72.4% to settle at $0.9551 on Thursday. Nutex Hea

Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 89% to $0.4242 after dipping 34% on W

Gainers Pintec Technology Holdings Limited (NASDAQ: PT) shares jumped 216.2% to close at $0.9058